This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Cost Control Remove Pharmaceuticals Remove Sourcing Related Topics
Co-Sourcing Regulations Efficiency Healthcare Insurance Manufacturing Marketing Management Government Engineering More Related Topics >
article thumbnail

Beyond the Big Three PBMs: Examining a Potential Trend

Perficient Digital Transformation

FEBRUARY 20, 2024

This ongoing struggle contributes to the broader atmosphere of tension within the pharmaceutical sector. Patients bear the financial burden of decisions made behind closed doors, emphasizing the need for a more transparent and patient-centered approach in the pharmaceutical ecosystem.

Pharmaceuticals 52
Pharmaceuticals Insurance Co-Sourcing Cost Control 52
article thumbnail

How To Overcome Three Challenges Facing Biotech Companies In 2021

Velocity Global

MARCH 26, 2021

In the face of steep internal costs and a lengthy process before generating revenue, it’s no surprise that the vast majority of biotech and life science companies see cost control as a major challenge. In fact, 87% of pharmaceutical companies believe they will have to comply with additional U.S.

Regulations 52
Regulations Government Pharmaceuticals Research 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 21,000+ professionals by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024